- Fund Type: SICAV
- Objective: Growth
- Asset Class: Equity
- Geographic Focus: Spain
Zanett Inversiones SICAV SA
+ Add to WatchlistS3085:SM
6.20 EUR 0.000.00%As of 10:00:40 ET on 05/24/2013.
Snapshot for Zanett Inversiones SICAV SA (S3085)
| Year To Date: | +4.45% | 3-Month: | +3.03% | 3-Year: | +1.12% | 52-Week Range: | 5.59 - 6.20 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +1.55% | 1-Year: | +9.49% | 5-Year: | -1.95% | Beta vs IBEX: | 0.46 |
Fund Profile & Information for S3085
Zanett Inversiones SICAV SA is an open-end investment company incorporated in Spain. The investment company's objective is capital growth. It primarily invests in equity securities.
| Inception Date: | 12-12-2006 | Telephone: | 3491-432-3910 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.nordkapp.es | ||
Fundamentals for S3085
| NAV | (on 2013-05-24) 6.20 |
|---|---|
| Assets (M) | (on 2013-04-03) 2.42 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for S3085
No dividends reported
Fees & Expenses for S3085
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | 0.45 |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for S3085
Filing Date: 05/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| GE 4 ¾ 07/30/14 | 100 | 108,040 | 4.826% |
| TELEFO 5.431 02/03/14 | 100 | 104,847 | 4.683% |
| SABSM 4 ½ 02/11/13 | 100 | 100,986 | 4.510% |
| BBVASM 4 03/22/13 | 100 | 99,933 | 4.463% |
| SANTAN 3 ¾ 02/28/13 | 100 | 99,651 | 4.451% |
| iShares MSCI Emerging Markets | 3,200 | 97,653 | 4.362% |
| SPGB 3.4 04/30/14 | 100 | 97,405 | 4.351% |
| BNY Mellon Global Funds plc - | 77,465 | 92,927 | 4.151% |
| PIMCO Funds Global Investors S | 7,813 | 92,502 | 4.131% |
| Telefonica SA | 6,674 | 59,646 | 2.664% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page